Evaluation of the biodegradable peripheral Igaki-Tamai stent in the treatment of de novo lesions in the superficial femoral artery: The GAIA study

JACC: Cardiovascular Interventions

Volumn 7, Issue 3, 2014, Pages 305-312

  Werner, Martin ^a   Micari, Antonio ^b   Cioppa, Angelo ^c   Vadalà, Giuseppe ^b   Schmidt, Andrej ^a   Sievert, Horst ^d   Rubino, Paolo ^c   Angelini, Annalisa ^e   Scheinert, Dierk ^a   Biamino, Giancarlo ^b  

^a Park Hospital Leipzig   (Germany)

^b Research Ettore Sansavini Health Science Foundation   (Italy)

^c Montevergine Clinic   (Italy)

^d CARDIOVASCULAR CENTER FRANKFURT   (Germany)

^e UNIVERSITY OF PADOVA   (Italy)

Author keywords

biodegradable stent; GAIA study; Igaki Tamai; peripheral artery disease; PLLA stent(s); superficial femoral artery

Indexed keywords

POLYLACTIC ACID;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTERY DISEASE; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL EXAMINATION; DEVICE SAFETY; ECHOGRAPHY; FEMALE; FOLLOW UP; FOREIGN BODY REACTION; GIANT CELL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IGAKI TAMAI STENT; IN-STENT RESTENOSIS; INFLAMMATORY CELL; MALE; MIDDLE AGED; MULTICENTER STUDY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OUTCOME ASSESSMENT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; REVASCULARIZATION; SUPERFICIAL FEMORAL ARTERY; SUPERFICIAL FEMORAL ARTERY DISEASE; SUPERFICIAL FEMORAL ARTERY STENT; TARGET LESION REVASCULARIZATION; WALKING IMPAIRMENT QUESTIONNAIRE; WALKING SPEED; ANGIOGRAPHY; ARTERY OCCLUSION; BIODEGRADABILITY; BIORESORBABLE VASCULAR STENT; CLINICAL EVALUATION; FEMORAL ARTERY; QUESTIONNAIRE; RESTENOSIS; SAFETY; SUPERFICIAL FEMORAL ARTERY OCCLUSION; TREATMENT OUTCOME; ULTRASOUND; ARTERIAL OCCLUSIVE DISEASES; BIODEGRADABLE IMPLANT; CLINICAL TRIAL; DOPPLER ECHOGRAPHY; PATHOPHYSIOLOGY; PROSTHESIS; STENT; SURGERY; TIME; WALKING;

ABSORBABLE IMPLANTS; AGED; ANGIOGRAPHY; ANKLE BRACHIAL INDEX; ARTERIAL OCCLUSIVE DISEASES; FEMALE; FEMORAL ARTERY; FOLLOW-UP STUDIES; HUMANS; MALE; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; QUESTIONNAIRES; STENTS; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, DUPLEX; WALKING;

EID: 84896544113     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2013.09.009     Document Type: Article

References (19)

1. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease). J Am Coll Cardiol 2006;47:1239-312.
2. Norgren L, Hiatt WR, Dormandy JA, et al., on behalf of the TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007; Suppl S:S5-67.
3. Schillinger M, Sabeti S, Loewe C, et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 2006;354:1879-88. (Pubitemid 43872689)
4. Krankenberg H, Schluter M, Steinkamp HJ, et al. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the Femoral Artery Stenting Trial (FAST). Circulation 2007;116:285-92. (Pubitemid 47196564)
5. Schillinger M, Minar E. Percutaneous treatment of peripheral artery disease: novel techniques. Circulation 2012;126:2433-40.
6. Scheinert D, Scheinert S, Sax J, et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol 2005;45:312-5. (Pubitemid 40094743)
7. Onuma Y, Serruys PW. Bioresorbable scaffold: the advent of a new era in percutaneous coronary and peripheral revascularization? Circulation 2011;123:779-97.
8. Nishio S, Kosuga K, Igaki K, et al. Long-term (>10 years) clinical outcomes of first-in-human biodegradable poly-l-lactic acid coronary stents: Igaki-Tamai stents. Circulation 2012;125:2343-53.
9. Ranke C, Creutzig A, Alexander K. Duplex scanning of the peripheral arteries: correlation of the peak velocity ratio with angiographic diameter reduction. Ultrasound Med Biol 1992;18:433-40.
10. Tamai H, Igaki K, Kyo E, et al. Initial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humans. Circulation 2000; 102:399-404. (Pubitemid 30490677)
11. Tosaka A, Soga Y, Iida O, et al. Classification and clinical impact of restenosis after femoropopliteal stenting. J Am Coll Cardiol 2012;59:16-23.
12. Laird JR, Katzen BT, Scheinert D, et al. Nitinol stent implantation versus balloon angioplasty for lesions in the superfi cial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv 2010;3:267-76.
13. Dick P, Wallner H, Sabeti S, et al. Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions. Catheter Cardiovasc Interv 2009;74:1090-5.
14. van der Giessen WJ, Lincoff AM, Schwartz RS, et al. Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation 1996;94:1690-7. (Pubitemid 26320276)
15. Zidar J, Lincoff A, Stack R. Biodegradable stents. In: Topol EJ, editor. Textbook of Interventional Cardiology. 2nd edition. Philadelphia, PA: Saunders, 1994:787-802.
16. Kearney M, Pieczek A, Haley L, et al. Histopathology of in-stent restenosis in patients with peripheral artery disease. Circulation 1997;95:1998-2002. (Pubitemid 27184264)
17. Schwartz RS, Holmes DR Jr., Topol EJ. The restenosis paradigm revisited: an alternative proposal for cellular mechanisms. J Am Coll Cardiol 1992;20:1284-93.
18. Berglund J, Guo Y, Wilcox JN. Challenges related to development of bioabsorbable vascular stents. EuroIntervention 2009; Suppl F:F72-9.
19. Bosiers M, Peeters P, D'Archambeau O, et al. AMS INSIGHT-absorbable metal stent implantation for treatment of below-the-knee critical limb ischemia: 6-month analysis. Cardiovasc Intervent Radiol 2009;32:424-35.